| HOME >> MEDICINE >> TECHNOLOGY |
Aged between 15 and 49 Years for the Year 2007 (includes
corresponding Graph/Chart) II-49
Asia-Pacific II-49
Central Asia & Eastern Europe II-50
Commonwealth of Independent States (CIS) II-50
Latin America (Including the Caribbean Islands) II-50
Sub Saharan Africa II-50
North Africa & the Middle East II-51
Developed Regions and High-Income Countries II-51
United States II-51
Table 27: New HIV Infection Cases among Men in the US
(2006): Percentage Breakdown by Mode of Infection
(includes corresponding Graph/Chart) II-51
Table 28: New HIV Infection Cases in the US (2006):Percentage Breakdown by Racial/Ethnic Groups (includescorresponding Graph/Chart) II-52
Table 29: New HIV Infection Cases among Women in the US
(2006): Percentage Breakdown by Mode of Infection
(includes corresponding Graph/Chart) II-52
Development of Treatment Options II-52
Categories of Vaccines for AIDS II-53
HIV Vaccines Under Development II-53
HIV Vaccines (Prophylactic/Therapeutic) Under Development:
As of 2010 II-53
Malaria Vaccine II-54
Therapeutic Vaccines Against Infectious Diseases: The
Challenges II-54
Melanoma: Prospects for Treatment II-54
Melanoma Vaccines under Development: As of 2010 II-54
Autoimmune Diseases II-55
How Do Autoimmune Diseases Occur II-55
Types of Autoimmune Diseases II-55
Need for Developing Autoimmune Therapeutic Vaccines II-55
Travel Vaccines: Opportunities II-55
SARS - A Review II-55
Vaccinations Recommended for Travel to High-Risk Areas II-56
Mechanisms for Vaccine Delivery II-57
Edible Vaccines II-57
Oral Vaccines II-59
Tablet Based Vaccines II-59
Mucosal Delivery II-59
Transdermal Patch Delivery II-59
3. MARKET TRENDS & ISSUES II-60Newer Vaccines in Pipeline to Ch
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |